Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
China flag China · Delayed Price · Currency is CNY
25.00
-0.45 (-1.77%)
At close: Feb 13, 2026

SHA:600645 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
1,4361,5501,5381,5071,4971,288
Other Revenue
35.8135.8152.0747.837.9431.38
1,4721,5851,5901,5551,5351,319
Revenue Growth (YoY)
-7.61%-0.27%2.24%1.27%16.41%-4.90%
Cost of Revenue
470.08497.75505.02510.29473.84451.09
Gross Profit
1,0021,0881,0851,0451,061867.81
Selling, General & Admin
663.02695.33719.77723.4749.78632.71
Research & Development
160.79182.11184.49146.12133.85111.78
Other Operating Expenses
23.4319.3919.1917.5916.5415.49
Operating Expenses
876.43924.48946.57901.67937.05774.3
Operating Income
125.47163.2138.14142.93124.4493.51
Interest Expense
-4.56-5.03-5.02-4.02-3.14-3.77
Interest & Investment Income
18.6524.429.5918.2316.2145.86
Earnings From Equity Investments
-14.3-14.3-11.85-7.96--
Currency Exchange Gain (Loss)
-3.2-3.21.51-2.370.12.04
Other Non Operating Income (Expenses)
-1.95-3.221.03-2-1.49-2.05
EBT Excluding Unusual Items
120.11161.84153.4144.82136.13135.59
Impairment of Goodwill
-----19.72-264.65
Gain (Loss) on Sale of Investments
-22.41-30.03-36.09-0.7579.095.72
Gain (Loss) on Sale of Assets
3.661.33.672.030.5120.4
Asset Writedown
-7.29-4.68-0.31-0.8-6.26-
Other Unusual Items
4.177.5211.929.933.213.84
Pretax Income
98.23135.95132.59155.21222.96-89.09
Income Tax Expense
41.5346.5934.0348.5371.7537.83
Earnings From Continuing Operations
56.789.3598.55106.68151.21-126.92
Minority Interest in Earnings
18.04117.96.34.110.06
Net Income
74.75100.35106.45112.99155.32-126.86
Net Income to Common
74.75100.35106.45112.99155.32-126.86
Net Income Growth
-30.44%-5.73%-5.78%-27.26%--
Shares Outstanding (Basic)
448456463471471470
Shares Outstanding (Diluted)
448456463471471470
Shares Change (YoY)
-1.13%-1.45%-1.69%0.02%0.17%4.01%
EPS (Basic)
0.170.220.230.240.33-0.27
EPS (Diluted)
0.170.220.230.240.33-0.27
EPS Growth
-29.64%-4.35%-4.17%-27.27%--
Free Cash Flow
279.47217.87210.4162.7193.22152.64
Free Cash Flow Per Share
0.620.480.460.350.410.33
Gross Margin
68.06%68.61%68.23%67.18%69.14%65.80%
Operating Margin
8.52%10.29%8.69%9.19%8.11%7.09%
Profit Margin
5.08%6.33%6.70%7.27%10.12%-9.62%
Free Cash Flow Margin
18.99%13.74%13.23%10.46%12.58%11.57%
EBITDA
196.84265.53281.74253.74227.35196.82
EBITDA Margin
13.37%16.75%17.72%16.32%14.81%14.92%
D&A For EBITDA
71.37102.33143.6110.81102.91103.31
EBIT
125.47163.2138.14142.93124.4493.51
EBIT Margin
8.52%10.29%8.69%9.19%8.11%7.09%
Effective Tax Rate
42.27%34.27%25.67%31.26%32.18%-
Revenue as Reported
1,4721,5851,5901,5551,5351,319
Advertising Expenses
-30.8632.9829.0232.4326.79
Source: S&P Global Market Intelligence. Standard template. Financial Sources.